Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis

NCT04692766 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Pericarditis

Interventions

BIOLOGICAL: RPH-104
DRUG: Placebo

Sponsor

R-Pharm International, LLC

Collaborators

[object Object]
[object Object]
[object Object]